does medicaid cover glp 1 drugs for weight loss Coverage of and Spending on GLP-1s Does Medicaid Cover GLP-1 Drugs?

Although rare, associations with nonarteritic anterior ischemic optic neuropathy, pancreatitis, medullary thyroid carcinoma, and acute kidney injury (AKI) have been reported, primarily through pharmacovigilance and case-based evidence

Yet, data on their safety and clinical utility during these reproductive windows remain limited

Summary Obesity is a chronic progressive disease with increasing prevalence in the United States and around the world

The GLP-1 receptor agonists used clinically are based on exendin-4 and native GLP-1 and are available as formulations for daily or weekly s.c

Type 2 diabetes mellitus (T2DM) is a widespread metabolic disorder characterized by insulin resistance and pancreatic -cell dysfunction, posing a substantial global health challenge

Indication expansion, such as approvals for additional metabolic and cardiovascular conditions, is broadening patient access and driving adoption